Sightline Wealth Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $421K | Sell |
|
|||||
|
2025
Q2 | $418K | Sell |
|
|||||
|
2025
Q1 | $407K | Sell |
|
|||||
|
2024
Q4 | $601K | Sell |
|
|||||
|
2024
Q3 | $734K | Sell |
|
|||||
|
2024
Q2 | $687K | Buy |
|
|||||
|
2024
Q1 | $706K | Sell |
|
|||||
|
2023
Q4 | $738K | Sell |
|
|||||
|
2023
Q3 | $735K | Buy |
|
|||||
|
2023
Q2 | $890K | Hold |
|
|||||
|
2023
Q1 | $890K | Sell |
|
|||||
|
2022
Q4 | $928K | Buy |
|
|||||
|
2022
Q3 | $685K | Buy |
|
|||||
|
2022
Q2 | $501K | Buy |
|
|||||
|
2022
Q1 | $300K | Buy |
|
|||||
|
2021
Q4 | $291K | Buy |
|